Literature DB >> 14640068

Payment policy and inefficient benefits in the Medicare+Choice program.

Steven D Pizer1, Austin B Frakt, Roger Feldman.   

Abstract

We investigated whether constraints on premium rebates by health plans in the Medicare+Choice program result in inefficient benefits. Since relationships between revenue and benefits could be confounded by unobserved variation in the cost of coverage, we took advantage of natural experiment that occurred following passage of the Benefits Improvement and Protection Act of 2000. Our findings indicate that benefits in zero premium plans were more sensitive to changes in payment rates than were benefits in plans that charged nonzero premiums. These results strongly suggest that current Medicare policy induces plans to offer benefits that are not valued by enrollees at or above their cost.

Mesh:

Year:  2003        PMID: 14640068     DOI: 10.1023/a:1023373630383

Source DB:  PubMed          Journal:  Int J Health Care Finance Econ        ISSN: 1389-6563


  8 in total

1.  Medicare+Choice: an interim report card.

Authors:  M Gold
Journal:  Health Aff (Millwood)       Date:  2001 Jul-Aug       Impact factor: 6.301

2.  Uncertain demand, the structure of hospital costs, and the cost of empty hospital beds.

Authors:  M Gaynor; G F Anderson
Journal:  J Health Econ       Date:  1995-08       Impact factor: 3.883

Review 3.  The effect of market structure on HMO premiums.

Authors:  D Wholey; R Feldman; J B Christianson
Journal:  J Health Econ       Date:  1995-05       Impact factor: 3.883

4.  Disparities in access to Medicare managed care plans and their benefits.

Authors:  T D McBride
Journal:  Health Aff (Millwood)       Date:  1998 Nov-Dec       Impact factor: 6.301

5.  A statistical analysis of reasons for East-West differences in hospital use.

Authors:  J R Knickman; A M Foltz
Journal:  Inquiry       Date:  1985       Impact factor: 1.730

6.  The value of health insurance: the access motive.

Authors:  J A Nyman
Journal:  J Health Econ       Date:  1999-04       Impact factor: 3.883

Review 7.  Premium rebates and the quiet consensus on market reform for Medicare.

Authors:  R Feldman; B E Dowd; R Coulam; L Nichols; A Mutti
Journal:  Health Care Financ Rev       Date:  2001

8.  Payment policy and competition in the Medicare+Choice program.

Authors:  Steven D Pizer; Austin B Frakt
Journal:  Health Care Financ Rev       Date:  2002
  8 in total
  8 in total

1.  Plan-provider integration, premiums, and quality in the Medicare Advantage market.

Authors:  Austin B Frakt; Steven D Pizer; Roger Feldman
Journal:  Health Serv Res       Date:  2013-06-26       Impact factor: 3.402

2.  Nothing for something? Estimating cost and value for beneficiaries from recent medicare spending increases on HMO payments and drug benefits.

Authors:  Steven D Pizer; Austin B Frakt; Roger Feldman
Journal:  Int J Health Care Finance Econ       Date:  2008-09-27

3.  Gold and silver health plans: accommodating demand heterogeneity in managed competition.

Authors:  Jacob Glazer; Thomas G McGuire
Journal:  J Health Econ       Date:  2011-06-28       Impact factor: 3.883

4.  Making Medicare advantage a middle-class program.

Authors:  Jacob Glazer; Thomas G McGuire
Journal:  J Health Econ       Date:  2013-02-01       Impact factor: 3.883

5.  Integrating risk adjustment and enrollee premiums in health plan payment.

Authors:  Thomas G McGuire; Jacob Glazer; Joseph P Newhouse; Sharon-Lise Normand; Julie Shi; Anna D Sinaiko; Samuel H Zuvekas
Journal:  J Health Econ       Date:  2013-12       Impact factor: 3.883

6.  Do Medicare Advantage Rebates Reduce Enrollees' Out-of-Pocket Spending?

Authors:  Lauren Hersch Nicholas; Shannon Wu
Journal:  Med Care Res Rev       Date:  2018-11-01       Impact factor: 3.929

7.  The impact of the Affordable Care Act on Medicare Advantage plan availability and enrollment.

Authors:  Christopher C Afendulis; Mary Beth Landrum; Michael E Chernew
Journal:  Health Serv Res       Date:  2012-05-11       Impact factor: 3.402

8.  Risk selection and benefits in the Medicare+Choice program.

Authors:  Roger Feldman; Bryan Dowd; Marian Wrobel
Journal:  Health Care Financ Rev       Date:  2003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.